Lisinopril
From Anvita Health Wiki
Contents |
Introduction
- Tradenames: Prinivil, Zestril.
Indications
Dosage
- Tabs: 2.5, 5, 10, 20, 40 mg.
Dosage-adjustment-in-renal-failure
* creatinine clearance dosage * 10-50 mL/min 50-75% of normal dose * < 10 mL/min 25-50% of normal dose
Pharmacokinetics
- onset of action: 1 hour
- peak hypotensive effect within 6 hours after oral dose
- duration of action 24 hours
- minimal protein binding
- elimination 1/2life
- about 12 hours
- prolonged in patients with renal insufficiency
- 10% of drug is excreted unchanged into the urine
- elimination via kidney
Adverse-effects
- infrequent (1-10%)
- dizziness, headache, fatigue, diarrhea, upper respiratory tract symptoms, cough, hypotension, increased BUN & creatinine
- uncommon (< 1%)
- chest discomfort, fever, flushing, malaise, angina pectoris, myocardial infarction, orthostatic hypotension, arrhythmias, tachycardia, peripheral edema, vasculitis, palpitations, pancreatitis, hepatitis, abdominal pain, anorexia, constipation, flatulence, dry mouth, gout, shoulder pain, depression, somnolence, insomnia, bronchitis, sinusitis, pharyngeal pain, urticaria, pruritis, diaphoresis, blurred vision, angioedema, syncope, neutropenia, bone marrow suppression
- chest discomfort, fever, flushing, malaise, angina pectoris, myocardial infarction, orthostatic hypotension, arrhythmias, tachycardia, peripheral edema, vasculitis, palpitations, pancreatitis, hepatitis, abdominal pain, anorexia, constipation, flatulence, dry mouth, gout, shoulder pain, depression, somnolence, insomnia, bronchitis, sinusitis, pharyngeal pain, urticaria, pruritis, diaphoresis, blurred vision, angioedema, syncope, neutropenia, bone marrow suppression
Drug-interactions
- coadministration of K+ sparing diuretics causes increased hyperkalemic effect
- coadministration with NSAIDs causes reduced antihypertensive response
- phenothiazines increase pharmacologic effects of ACE inhibitors
- allopurinol in combination results in high risk of hyper- sensitivity reactions
- lisinopril increases plasma lithium & digoxin levels
- drug interaction(s) of renin-angiotensin inhibitors with trimethoprim-sulfamethoxazole
- drug interaction(s) of lithium carbonate with ACE inhibitors
- drug interaction(s) of ACE inhibitors with aliskiren
- drug interaction(s) of ACE inhibitors with angiotensin II receptor antagonists
- drug interaction(s) of potassium chloride with ACE inhibitors
- drug interaction(s) of spironolactone with ACE inhibitors
- drug interaction(s) of diuretics with ACE inhibitors
- drug interaction(s) of beta blockers with ACE inhibitors
- drug interaction(s) of NSAIDs with ACE inhibitors
- drug interaction(s) of ACE inhibitors, angiotensin II receptor antagonists & beta-blockers
- drug interaction(s) of NSAIDs, diuretics & ACE inhibitors
Mechanism-of-action
- dicarocyl-containing ACE inhibitor
- inhibits conversion of angiotensin I to angiotensin II
- inhibits degradation of bradykinin
More General Terms
- pyrrolidine; tetrahydropyrrole
- amide
- amine
- carboxylic acid
- angiotensin-converting enzyme [ACE] inhibitor
Internet Database
PubChem: 55186
PubChem: 55187
PubChem: 3937
References
- Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1990. pg 760-1
- The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
- Kaiser Permanente Northern California Regional Drug Formulary, 1998
- Journal Watch 23(4):34, 2003 BMJ 322:19, 2001
